Waukesha, WI -- MAY 9, 2012 -- GE Healthcare announced today, during the Heart Rhythm Society's (HRS) 33rd Annual Scientific Sessions, a continued commitment to electrophysiology (EP) by delivering new technologies for ablation guidance, dose reduction, and signal optimization.
GE Healthcare also announced the extension of their current co-distribution agreement with Biosense Webster with a three-year roadmap development collaboration that aims to deliver tighter integration between their CardioLab* recording system and CARTO® 3 navigation system.
business unit
tags
business unit
business unit
tags